Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

APOA1 antibody (AA 83-167)

The Mouse Monoclonal anti-APOA1 antibody has been validated for IHC (f). It is suitable to detect APOA1 in samples from Human.
Catalog No. ABIN7126527

Quick Overview for APOA1 antibody (AA 83-167) (ABIN7126527)

Target

See all APOA1 Antibodies
APOA1 (Apolipoprotein A-I (APOA1))

Reactivity

  • 133
  • 43
  • 28
  • 22
  • 17
  • 13
  • 6
  • 3
  • 3
  • 2
  • 2
  • 1
Human

Host

  • 115
  • 82
  • 19
  • 5
  • 3
  • 3
  • 2
Mouse

Clonality

  • 139
  • 89
Monoclonal

Conjugate

  • 133
  • 38
  • 17
  • 11
  • 8
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
This APOA1 antibody is un-conjugated

Application

  • 165
  • 101
  • 82
  • 72
  • 65
  • 20
  • 12
  • 11
  • 9
  • 8
  • 8
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Binding Specificity

    • 27
    • 17
    • 16
    • 11
    • 6
    • 5
    • 5
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 83-167

    Specificity

    Apolipoproteins are protein components of plasma lipoproteins. The human apoA-I gene encodes a single chain, 243 amino acid protein which promotes cholesterol efflux from tissues to the liver for excretion. Apolipoprotein A-I is the major protein component of high density lipoprotein (HDL) in the plasma. It can function as a cofactor for lecithin cholesterolacyltransferase (LCAT), which is responsible for the formation of most plasma cholesteryl esters. The human apoA-II gene encodes the second most abundant protein of HDL particles, where it influences plasma levels of free fatty acids (FFA). The human apoA-IV gene encodes a 396 amino acid preprotein, which after proteolytic processing is secreted from the intestine in association with chylomicron particles. ApoA-IV is a potent activator of LCAT in vitro. The human apoA-V gene encodes a 366 amino acid protein that is believed to be an important determinant of plasma triglyceride levels.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Human recombinant APOA1 protein fragment (around aa 83-167) (exact sequence is proprietary)

    Isotype

    IgG1
  • Application Notes

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human liver.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    APOA1 (Apolipoprotein A-I (APOA1))

    Alternative Name

    APOA1

    Background

    ApoA1, Brp14, high density lipoprotein uptake, Ltw1, Lvtw1, Sep1, Sep2,Apolipoprotein A1 / APOA1
    Cellular localisation: Secreted.

    Molecular Weight

    28kDa

    Gene ID

    335, 93194

    UniProt

    P02647

    Pathways

    Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
You are here:
Chat with us!